Key result
Endovascular aortic arch treatment lacks RCTs versus open surgery, requiring individualized interdisciplinary prosthesis selection.
Why the study?
Published studies on endovascular treatment of aortic arch pathologies vary widely, and randomized controlled trials directly comparing it with open aortic arch replacement surgery are lacking.
Endovascular treatment of aortic arch pathologies requires individualized decision-making by an interdisciplinary team due to the lack of randomized trials comparing it with open surgery.
No takes yet. Share an insight, caveat, or question.
Mandates interdisciplinary individualized prosthesis selection in aortic arch endovascular repair; leaves open superiority versus open surgery pending RCTs.
The published studies vary widely in case numbers and patient collectives; randomized controlled trials are lacking, as is a direct comparison with open aortic arch replacement surgery. Improvements in aortic arch prostheses enable improved, more individualized treatment; the risk profile of each patient must be considered by the interdisciplinary aorta team along with the advantages and disadvantages of the various available types of prosthesis.
Kunzmann et al. (2026) studied this question. Endovascular treatment of aortic arch pathologies lacks RCTs and direct comparisons to open surgery, requiring individualized prosthesis choice by interdisciplinary teams.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: